GPT Infraprojects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 29, 2025, 8:50 pm

Competitors of GPT Infraprojects Ltd

All Competitor Stocks of GPT Infraprojects Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:10 am

Below is a detailed analysis of the quarterly data for GPT Infraprojects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 313.00 Cr.. The value appears to be declining and may need further review. It has decreased from 381.00 Cr. (Mar 2025) to 313.00 Cr., marking a decrease of 68.00 Cr..
• For Expenses, as of Jun 2025, the value is 276.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 342.00 Cr. (Mar 2025) to 276.00 Cr., marking a decrease of 66.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 12.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 8.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 33.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 25.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.86. The value appears to be declining and may need further review. It has decreased from 1.92 (Mar 2025) to 1.86, marking a decrease of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:16 am

Growth

Last Updated: September 5, 2025, 5:15 am

Balance Sheet

Last Updated: July 25, 2025, 3:09 pm

Below is a detailed analysis of the balance sheet data for GPT Infraprojects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 68.00 Cr..
• For Reserves, as of Mar 2025, the value is 397.00 Cr.. The value appears strong and on an upward trend. It has increased from 244.00 Cr. (Mar 2024) to 397.00 Cr., marking an increase of 153.00 Cr..
• For Borrowings, as of Mar 2025, the value is 129.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 193.00 Cr. (Mar 2024) to 129.00 Cr., marking a decrease of 64.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 289.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 231.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 58.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 941.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 726.00 Cr. (Mar 2024) to 941.00 Cr., marking an increase of 215.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 164.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 164.00 Cr., marking an increase of 29.00 Cr..
• For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 736.00 Cr.. The value appears strong and on an upward trend. It has increased from 566.00 Cr. (Mar 2024) to 736.00 Cr., marking an increase of 170.00 Cr..
• For Total Assets, as of Mar 2025, the value is 941.00 Cr.. The value appears strong and on an upward trend. It has increased from 726.00 Cr. (Mar 2024) to 941.00 Cr., marking an increase of 215.00 Cr..

Notably, the Reserves (397.00 Cr.) exceed the Borrowings (129.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for GPT Infraprojects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.55. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 6.55, marking a decrease of 3.39.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.55. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 6.55, marking a decrease of 3.39.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has decreased from 12.43 (Mar 24) to 7.32, marking a decrease of 5.11.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.43. It has decreased from 51.67 (Mar 24) to 41.43, marking a decrease of 10.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.43. It has decreased from 51.67 (Mar 24) to 41.43, marking a decrease of 10.24.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 94.32. It has decreased from 175.48 (Mar 24) to 94.32, marking a decrease of 81.16.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.22. This value is within the healthy range. It has decreased from 21.94 (Mar 24) to 11.22, marking a decrease of 10.72.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.83. This value is within the healthy range. It has decreased from 19.23 (Mar 24) to 9.83, marking a decrease of 9.40.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.78. This value is within the healthy range. It has decreased from 13.60 (Mar 24) to 7.78, marking a decrease of 5.82.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.93. This value is within the healthy range. It has decreased from 9.71 (Mar 24) to 5.93, marking a decrease of 3.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.34. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 6.34, marking a decrease of 3.60.
• For PBDIT Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has decreased from 12.50 (Mar 24) to 11.89, marking a decrease of 0.61.
• For PBIT Margin (%), as of Mar 25, the value is 10.41. This value is within the healthy range. It has decreased from 10.95 (Mar 24) to 10.41, marking a decrease of 0.54.
• For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has increased from 7.75 (Mar 24) to 8.24, marking an increase of 0.49.
• For Net Profit Margin (%), as of Mar 25, the value is 6.28. This value is within the healthy range. It has increased from 5.53 (Mar 24) to 6.28, marking an increase of 0.75.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.71. This value is below the healthy minimum of 8. It has increased from 5.66 (Mar 24) to 6.71, marking an increase of 1.05.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.29. This value is within the healthy range. It has decreased from 19.11 (Mar 24) to 15.29, marking a decrease of 3.82.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.16. This value is within the healthy range. It has decreased from 30.96 (Mar 24) to 21.16, marking a decrease of 9.80.
• For Return On Assets (%), as of Mar 25, the value is 8.48. This value is within the healthy range. It has increased from 7.94 (Mar 24) to 8.48, marking an increase of 0.54.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.04, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.24, marking a decrease of 0.38.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.43. It has increased from 1.35 (Mar 24) to 1.43, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.92, marking an increase of 0.49.
• For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.46, marking an increase of 0.40.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.05. This value exceeds the healthy maximum of 8. It has increased from 0.35 (Mar 24) to 8.05, marking an increase of 7.70.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 38.82. This value is within the healthy range. It has increased from 35.19 (Mar 24) to 38.82, marking an increase of 3.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.83. This value is within the healthy range. It has increased from 27.64 (Mar 24) to 31.83, marking an increase of 4.19.
• For Earning Retention Ratio (%), as of Mar 25, the value is 61.18. This value is within the healthy range. It has decreased from 64.81 (Mar 24) to 61.18, marking a decrease of 3.63.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.17. This value is within the healthy range. It has decreased from 72.36 (Mar 24) to 68.17, marking a decrease of 4.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.48. This value is within the healthy range. It has increased from 3.90 (Mar 24) to 5.48, marking an increase of 1.58.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.90. This value is within the healthy range. It has increased from 2.73 (Mar 24) to 3.90, marking an increase of 1.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,607.43. It has increased from 1,060.45 (Mar 24) to 1,607.43, marking an increase of 546.98.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.35, marking an increase of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 11.34. This value is within the healthy range. It has increased from 8.31 (Mar 24) to 11.34, marking an increase of 3.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 1.26, marking an increase of 0.38.
• For Retention Ratios (%), as of Mar 25, the value is 61.17. This value is within the healthy range. It has decreased from 64.80 (Mar 24) to 61.17, marking a decrease of 3.63.
• For Price / BV (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 2.97 (Mar 24) to 2.87, marking a decrease of 0.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 1.26, marking an increase of 0.38.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness